tiprankstipranks
Ars Pharmaceuticals, Inc. (SPRY)
NASDAQ:SPRY
US Market
SPRY
ARS Pharmaceuticals
RESEARCH TOOLSreports
Want to see SPRY full AI Analyst Report?

ARS Pharmaceuticals (SPRY) Revenue

576 Followers
StatisticsMarket CapRevenue

ARS Pharmaceuticals Revenue

ARS Pharmaceuticals had a revenue of 22.68M in the quarter ending Mar 31, 2026, with -19.25%. This bring the company's revenue in the last twelve months to 98.99M, Decreased 17.45%. In the fiscal year ending Dec 31, 2025, ARS Pharmaceuticals had annual revenue of 84.28M with -5.46% growth.
Revenue (ttm)
98.99M
Revenue Growth
1.92%
P/S Ratio
11.37
Revenue/Employee
$543,729
Employees
155
Market Cap
$958.28M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
84.28M-4.87M-5.46%
Dec 31, 2024
89.15M89.12M+297,063.33%
Dec 31, 2023
30.00K-1.29M-97.72%
Dec 31, 2022
1.32M-4.19M-76.10%
Mar 31, 2022
5.51M-12.33M-69.13%
Dec 31, 2020
17.84M―+∞%
Dec 31, 2019
―――
Dec 31, 2018
―――